Contact Lenses: A Promising Drug Delivery System by Vedaga, S. B. et al.
Vedaga et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):1105-1108 
ISSN: 2250-1177                                                                                  [1105]                                                                                    CODEN (USA): JDDTAO 
Available online on 25.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                           Review Article 
Contact Lenses: A Promising Drug Delivery System 
S. B. Vedaga1, S.B. Gondkar1*, R.B. Saudagar2 
1 Department of Pharmaceutics, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik-422213, Maharashtra, India 
2 Department of Pharmaceutical Organic Chemistry, R. G. Sapkal College of Pharmacy,   Anjaneri, Nashik-422213, Maharashtra, 
India 
 
ABSTRACT 
Presently, around 100 million people are estimated to be wearing contact lenses, and the number is growing exponentially. 
Though the main use of contact lenses is for improving ametropia problems, they also hold attention as therapeutic devices for 
the treatment of ocular pain, promotion of corneal healing, maintenance of corneal epithelial hydration, and drug delivery. 
Contact lenses are developing as an substitute ophthalmic drug delivery system to resolve the problems of the conventional 
topical application methods. The interest in evolving contact lenses for drug delivery has expressively increased in the last decade 
as several new techniques have been developed for designing contact lenses for extended drug delivery. The newest studies show 
that contact lenses are able to achieve prolonged release of a few weeks without any significant effect on critical lens properties. 
The future appears promising for drug eluting contact lenses but several challenges remain to be overcome regarding processing 
and storage issues, lack of use in the elderly population, regulatory issues, high costs of clinical studies and cost-benefit analysis. 
Contact lenses are attractive for ocular drug delivery systems as significantly prolong the residence time of the drug in the  eye, 
high degree of comfort which improve patient compliance, higher efficiency and low side effects and, hence increase the ocular 
drug bioavailability. 
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INTRODUCTION: 
Most ophthalmic drugs are applied topically in the form of 
eyedrops. Adequate therapy from eyedrops is achieved 
either by providing a sufftcient magnitude of the pulse, so 
that its effect extends for a useful period of time, or by giving 
more frequent applications of a less concentrated pulse[1-4]. 
Ocular drug delivery is troubled by the barriers shielding the 
eye. The bioavailability of the active drug substance is often 
the main barrier to overcome. Conventional ocular dosage 
form, including eye drops, is no longer sufficient to fight 
against ocular diseases. Apart from this contact lenses have 
been widely used to correct vision by directly placing them 
on the outer surface of the eyes. Beginning recently, contact 
lenses have also been used for therapeutic purposes. Ocular 
drug delivery to the eyes through contact lenses has received 
much attention order to achieve an effective drug delivery 
system using contact lenses, several technical issues, such as 
short drug release time and limited drug loading, should be 
addressed. Researchers explored various strategies including 
vitamin loading, molecular imprinting, and nanoparticle 
embedding, to overcome the hurdles[6] . Several eye diseases 
like cataract, age-related macular degeneration, diabetic 
retinopathy, glaucoma etc have reported to affect several 
millions of the world population. The intraocular and 
systemic therapy is not widely used due to their intrinsic 
limitations. The topical route is the most appropriate therapy 
for local and controlled delivery of bioactive and therapeutic 
molecules to the eye, as it offers higher patient compliance, 
better proximity to the infected site and a have less potential 
systemic side effects. Among the topical formulations, 
conventional topical eye drops is well recognized. However, 
the achievement of topical therapy is limited by some issues 
such as low bioavailability (>1%), short residence time, low 
corneal permeability. Therefore products such as contact 
lenses, have been launched in the market while many others 
are in pre-clinical and clinical stages[7]. Contact lenses 
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includes polymeric/ mucoadhesive formulations, hydrogels, 
in situ gelling systems etc. Contact lenses are particularly 
attractive for ODDS as these significantly increase the 
residence time (typically days) of the drug in the eye, high 
degree of comfort and enhances the drug bioavailability 
considerably [8] . Contact lenses for ophthalmic drug delivery 
widespread, due to their advantages like extended wear and 
more than 50% bioavailability. To attain controlled and 
sustained drug delivery from contact lenses, researchers are 
working on various systems like polymeric nanoparticles, 
microemulsion, micelle, liposomes, use of vitamin E, etc. 
Many scientists are working on different areas of therapeutic 
contact lenses to treat ocular diseases by developing 
techniques like soaking method, molecular imprinting, 
entrapment of drug colloidal nanoparticles, drug plate/film, 
ion ligand polymeric systems, supercritical fluid technology, 
etc [9]. 
METHODOLOGY TO DESIGN THERAPEUTIC 
CONTACT LENSES: 
1. Soaking method 
It is the most simple, cost effective and conventional way to 
load drug into the contact lenses. This method involves 
soaking the preformed contact lenses in the drug solution, 
followed by drug uptake and release in pre- and post-lens 
tear film. The contact lenses are available as solid or may 
have the cavity for receiving the drug solution. Their drug 
reservoir ability strongly depends on the water content, 
thickness of lenses, the molecular weight of the drug, soaking 
time period and concentration of drug in soaking solution. As 
an alternative, one can also insert contact lenses into the 
eyes and then apply eye drops. By this means, drugs can be 
absorbed and released by the contact lens. Use of therapeutic 
contact lenses prepared by soaking method, to deliver 
ophthalmic drugs like timolol, pilocarpine, dexamethasone, 
hyaluronic acid, brimonidine tartrate etc. have been explored 
by many researchers[9,10]. 
2. Molecular imprinting 
The utilization of the molecular imprinting technique is an 
important progress in this line of work. The spatial 
arrangement of monomers becomes permanent when the 
polymerization process is completed. Molecular imprinting 
(MI) is one of the advanced methodologies using hydrogel 
contact lenses for high drug loading and controlled drug 
delivery. The procedure consists in synthesizing the contact 
lens in the presence of the drug molecules which act as a 
mold causing monomers to arrange themselves according to 
their affinity. The procedure consists in synthesizing the 
contact lens in the presence of the drug molecules which act 
as a mold causing monomers to arrange themselves 
according to their affinity. The monomers in the hydrogel 
matrix are prepared in such a way that high drug affinity 
molecular sites are created. These molecular imprinted sites 
mimic the drug’s receptors, which increase drug loading 
capacity[9,13]. 
Types of hydrogels: 
1. Poly-2-hydroxyethylmethacrylate (pHEMA) hydrogels. 
2. HPMA copolymer 
3. Acrylamide (AAm) hydrogel 
4. Silicon hydrogel 
4. NHS–PEG–biotin hydrogel[10]. 
3. Colloidal nanoparticles loaded therapeutic contact 
lens 
The technique is based on the ability of colloidal 
nanoparticles (polymeric nanoparticles, liposomes, 
niosomes, microemulsion, micelles, etc.) to entrap or 
encapsulate drug and control its release rate from contact 
lenses. Such formulated nanoparticular system (10 to 100 
nm) is dispersed in HEMA monomers and polymerized using 
ethylene glycol-dimethacrylate (EGDMA) and photo initiator 
(Darocur_) to fabricate therapeutic contact. Drug laden 
nanoparticles prevent the interaction of drug with 
polymerization mixture and also offer additional resistance 
to drug release. Thus the nanoparticles loaded contact lenses 
can deliver drugs at controlled rate for extended period of 
time. Drug loaded nanoparticles or globules (microemulsion) 
also bypass, to some extent, drug metabolism from the 
enzymes like lysosomes, present in the tear/corneal 
epithelial surface. This technique is successful in developing 
therapeutic contact lenses for extended drug delivery, while 
at the same time the transparency (optical), oxygen 
permeability, ion permeability, mechanical properties, and 
swelling behavior of contact lenses was altered for comfort 
wear[9].  
4. Polymeric nanoparticles 
Many researchers have done their research upon polymeric 
nanoparticles using biodegradable and non-biodegradable 
polymers, to formulate therapeutic contact lenses to treat 
ocular diseases. These polymeric nanoparticles are 
developed to treat glaucoma, by dispersing timolol loaded 
propoxylated glyceryl triacylate (PGT) nanoparticles in 
contact lenses. This system showed sustained release, the 
incorporation of nanoparticle in the silicone hydrogel contact 
lenses caused reduction in both ion and oxygen permeability, 
and an increase in storage modulus, suggesting the limitation 
of the technique [9,12]. 
 
Table 1: Characteristics of various polymers as vehicle for therapeutic contact lenses[10,12] 
Sr. No. Polymer Characteristics 
1. Propoxylated glyceryl triacrylate (PGT) Polymer having multiple vinyl functionalities 
2. Polycaprolactone (PCL) Hydrophobic and FDA-approved bioresorbable polymer without toxic 
byproducts 
3. Chitosan Cationic polysaccharide polymer with good biocompatibility and 
biodegradability including lysozyme-related degradability 
4. poly-(lactic-co-glycolic acid) (PLGA) Biocompatible, biodegradable and FDA-approved polymer that can change 
properties by varying the ratio of glycolic acid to lactic acid 
5. Poly (D,L-lactide)-dextran (Dex-b-PLA) Core-shell structured nanoparticles containing  PLA core and dextran 
outer shell 
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5. Cyclodextrins 
In another approach, polymers like cyclodextrins (CDs) and 
their derivatives were used to achieve sustained drug 
delivery of hydrophobic drugs. CDs can accommodate many 
different hydrophobic molecules in their hydrophobic 
interior (ringshaped structure), to achieve controlled drug 
delivery. The incorporation of b-CD in the hydrogels resulted 
in increased swelling and tensile strength. The cyclodextrins 
loaded contact lenses are effective to treat glaucoma. Invitro 
studies, reported an increase in the drug solubility in poly-
CD, an increase of its concentration in the cornea and an 
extended release over several weeks. 
6. Liposomes 
Liposomes are biocompatible and biodegradable, due to 
their biological membrane-like structure and used in 
numerous drug delivery applications including ophthalmic 
drug delivery through contact lenses. Multilamellar 
lipososmes showed greater sustained release in comparison 
to REL liposomes, because of the presence of several lipid 
bilayers[9]. 
7. Microemulsion and micelles 
Drug-loaded microemulsion and micelles loaded therapeutic 
contact lenses showed promising results, due to their 
thermodynamic stability, easy preparation, high drug-
loading capacity, increased wettability (low protein 
adherence) and easy tailoring of drug release pattern. Due to 
nano size (5100 nm) the optical property of hydrogels 
remained unaltered eg. timolol-contact lenses with o/w type. 
The microemulsion showed controlled release of timolol, due 
to the presence of a tightly packed surfactant at the oil–water 
interface. This system involves use of surfactant. The 
presence of surfactant did not alter the optical property of 
the contact lenses, and also had the advantage of increase in 
wettability, i.e. reduction in protein absorption on contact 
lens surface[9]. 
8. Use of vitamin E 
To improve the drug-release duration Vitamin E is used as 
transport barriers for drug molecules. The release of timolol 
was significantly extended by increasing Vitamin E loading 
from 10 to 40% in contact lenses, while at the same time 
complicating oxygen and ion permeability[9]. 
9. Supercritical fluid technology 
Supercritical fluid technology (SCF) is one of the most 
effective technologies to load/impregnate both hydrophilic 
and hydrophobic drug in contact lenses using supercritical 
solvent like CO2. Impregnation process involve dissolution of 
drug in supercritical solvent like CO2 (at subcritical or 
supercritical conditions), followed by interaction with 
hydrogel contact lenses. The drug loading amount and its 
release kinetics are controlled by tailoring operational 
parameters like pressure, temperature, processing time and 
depressurization rate[9]. 
CHARACTERISTICS OF MEDICATED CONTACT 
LENSES 
(1) Transparency Of The Lens: 
(2) Oxygen Permeability: 
(3) Glass Transition Temperature: 
(4) Wettability: 
(5) Water Content: 
(6) Drug Loading In Preformed Lenses: 
1) Transparency of the lens: 
Optical clarity is important during developing contact lens 
and it should be maintained after incorporation of drugs. 
Novel approaches have enabled to generate contact lens drug 
delivery systems with acceptable transparency, although it 
could be improved in some cases. For instance, contact 
lenses formulated with advanced techniques such as 
molecular imprinting and supercritical solvent approaches, 
loaded liposomes and microemulsions, exhibited good 
transparency[1,8]. 
2) Oxygen permeability: 
Drug eluting contact lens should allow transfer of oxygen to 
the eyes since low oxygen permeability can cause severe side 
effects, such as corneal edema. Hence, the prepared lenses 
should allow free transfer of oxygen to the eyes and any low 
oxygen transfer eventually causes severe side effects. To 
avoid hypoxia, a minimum value of oxygen transmissibility 
(Dk/t) around 125 has been suggested. 
Eg. The silicone hydrogel contact lens, also known as 
siloxane lens, show impressive permeability while retaining 
the comfort, wettability and biofilm resistance of non-silicon 
based hydrogels[1,8].  
3) Glass transition temperature: 
The Tg (Glass transition temperature) of contact lenses is not 
expected to alter during the drug loading process or due to 
incorporation of additives. Glass transition temperature has 
been measured in drug eluting contact lenses manufactured 
by various approaches. Several studies indicate that the 
contact lenses manufactured by various approaches have not 
shown any significant effect on Tg. Further, the alteration in 
Tg on addition of βCD was found to be insignificant, which 
suggests that the grafted βCD has little or no effect on the 
degree of cross-linking of the hydrogels or the stiffness of the 
network[1,8]. 
4) Wettability: 
Wettability of contact lenses is a critical variable that affects 
their physiological compatibility and the stability of the 
prelens lacrimal fluid. It can be determined by contact angle 
measurements. Hydrophobic polymers will repel the water 
that makes up a majority of the tear surface. This disrupts 
the tear flow and results in the deposition of an albumin film 
on the lens, which eventually reduces the effectiveness of the 
contact and can cause infection and/or irritation. Therefore, 
if a contact lens surface is highly hydrophobic it needs to be 
made hydrophilic. Doping the polymer or treating the 
surface of the polymer can do this change in the morphology 
of the surface[1,8]. 
5) Water content 
Water content of contact lenses is crucial as it likely impacts 
comfort and an increase in the water content enhances the 
oxygen permeability of contact lenses. The permeability of 
the lens is proportional to the amount of water in the lens. As 
the percent weight of water increases in the lens, the 
permeability increases linearly. The ability of lenses to 
absorb large amounts of water also makes them highly 
hydrophilic. These attributes gives soft contact lenses the 
ability to achieve greater permeability and could be used for 
extended wear without disturbing the eye. However, 
achieving greater permeability is a complex issue as increase 
in water content will eventually loose the polymer strength. 
This can lead to tearing or scratching of the lens[1,8]. 
Vedaga et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):1105-1108 
ISSN: 2250-1177                                                                                  [1108]                                                                                    CODEN (USA): JDDTAO 
CONTACT LENSES FOR OCULAR DRUG DELIVERY 
1. Allergic conjunctivitis 
Allergic conjunctivitis affects up to 40% of the general 
population, with seasonal allergic conjunctivitis accounting 
for up to 90% of these ocular cases. Antihistamines, such as 
ketotifen fumarate, are used to alleviate the sign and 
symptoms of allergic conjunctivitis through multiple 
pharmacological actions. In in vitro assays, all the contact 
lenses released an amount of ketotifen fumarate higher than 
the dosage provided by eye drops with the majority of the 
drug released within the first hour[1,15]. 
2. Dry eye 
The dry eye syndrome is a multifactorial disease of the tears 
and the ocular surface, associated with discomfort 
symptoms, visual disturbance, and tear film instability. In 
severe cases, this may lead to ocular surface damage. 
Common clinical signs of a patient with dry eye syndrome 
include inflammation, increased osmolarity, decreased tear 
breakup time, and ocular surface epithelial damage. Various 
molecules working as rewetting agents, such as hyaluronic 
acid or hydroxypropyl methylcellulose, have been also 
included in SCLs and their subsequent release have been 
analyzed. This lens combination device can provide great 
comfort in dry eyes and it can be particularly valuable for 
combating contact lens-induced dry eye[1,15]. 
3. Glaucoma 
Glaucoma is a group of progressive optic neuropathies, 
characterized by the damage caused to the optic nerve, fiber 
layer, and ganglion cells. If it is not treated, it results in visual 
field loss.An important risk factor for the nerve damage is 
the elevated intraocular pressure (IOP), and the restoration 
of the IOP to the normal level is the most common treatment 
for glaucoma. Several different classes of drugs are currently 
prescribed with this purpose, such as prostaglandin analogs, 
beta-adrenergic receptor antagonists, carbonic anhydrase 
inhibitors, and alpha2-adrenergic agonists Patients wearing 
the contact lenses for 30 min per day for 2 weeks showed 
IOP values equivalent to those obtained with previous eye 
drop treatment and no ocular toxicity was observed[1,15,16].  
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